David Hipkiss

David Hipkiss

Vorsitzender bei
AlveoGene Ltd.
56 Jahre
Process Industries
Health Technology
Finance

Profil

David John Hipkiss was the founder of Prosonix Ltd. which was founded in 2006, where he held the title of Chief Executive Officer from 2006 to 2012.
He is currently the Chairman of AlveoGene Ltd. since 2023.
Mr. Hipkiss's former jobs include being the Chief Executive Officer & Director of Enesi Pharma Ltd., a Principal at Air Products & Chemicals, Inc. and The Dow Chemical Co., the General Manager of Accentus LLC and Accentus Medical Ltd., a Principal at Chirotech Technology Ltd. and Ascot Plc, and the Chief Business Officer of Niox Group Plc.
Mr. Hipkiss received an undergraduate degree from the University of Birmingham.

Aktive Positionen von David Hipkiss

UnternehmenPositionBeginn
Vorsitzender 01.07.2023

Ehemalige bekannte Positionen von David Hipkiss

UnternehmenPositionEnde
Corporate Officer/Principal -
Vorstandsvorsitzender 01.07.2022
Ascot Plc
Corporate Officer/Principal -
NIOX GROUP PLC Corporate Officer/Principal -
AIR PRODUCTS & CHEMICALS, INC. Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von David Hipkiss im Detail an

Ausbildung von David Hipkiss

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

4

Beziehungen ersten Grades

11

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen11

Process Industries

Process Industries

Technology Services

Consumer Services

Distribution Services

Health Technology

Finance

Ascot Plc

Health Services

Health Technology

Finance

  1. Börse
  2. Insiders
  3. David Hipkiss